This product is sold for research purposes only. It is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. Purchaser acknowledges that this material is for laboratory research use only.
Retatrutide is a synthetic triple-receptor-agonist peptide targeting GLP-1, GIP, and glucagon receptors in cellular models. For research purposes only.
Investigated in cellular and receptor-binding research for incretin-receptor crosstalk and metabolic-signaling pathways. In-vitro applications only.
Price range: $129.00 through $219.00
2381089-83-2
C221H343FN50O64
4,731.40 g/mol
Triple-agonist peptide (GLP-1 / GIP / glucagon receptor)
Store at -20°C protected from light.
Reconstitute with bacteriostatic water for research protocols.
Batch ELV-RET-2410 · HPLC + MS verified
